Forte Financial Statements From 2010 to 2025

FBRX Stock  USD 5.50  0.02  0.36%   
Forte Biosciences financial statements provide useful quarterly and yearly information to potential Forte Biosciences investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Forte Biosciences financial statements helps investors assess Forte Biosciences' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Forte Biosciences' valuation are summarized below:
Market Capitalization
35.3 M
Earnings Share
(16.38)
We have found one hundred twenty available fundamental signals for Forte Biosciences, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to verify all of Forte Biosciences prevailing market performance against the performance between 2010 and 2025 to make sure the company can sustain itself down the road. Market Cap is likely to drop to about 28.3 M in 2025. Enterprise Value is likely to drop to about 15.3 M in 2025

Forte Biosciences Total Revenue

0.0

Check Forte Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Forte Biosciences' main balance sheet or income statement drivers, such as Interest Income of 1.3 M, Depreciation And Amortization of 7.7 K or Interest Expense of 14.5 K, as well as many indicators such as Price To Sales Ratio of 9.98, Dividend Yield of 0.0 or PTB Ratio of 0.8. Forte financial statements analysis is a perfect complement when working with Forte Biosciences Valuation or Volatility modules.
  
Check out the analysis of Forte Biosciences Correlation against competitors.
For more information on how to buy Forte Stock please use our How to Invest in Forte Biosciences guide.

Forte Biosciences Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets43.2 M35.1 M54.7 M
Slightly volatile
Short and Long Term Debt Total13.5 M7.9 M14.3 M
Slightly volatile
Other Current LiabilitiesMM4.6 M
Slightly volatile
Total Current LiabilitiesM3.3 M6.6 M
Pretty Stable
Accounts Payable1.3 M1.3 M1.5 M
Very volatile
Cash13.1 M13.8 M19.9 M
Slightly volatile
Non Current Assets Total558.3 K587.7 K1.6 M
Slightly volatile
Non Currrent Assets Other831.9 K489.6 K1.2 M
Slightly volatile
Long Term Debt16.7 M30.1 M20.2 M
Slightly volatile
Cash And Short Term Investments41 M33.4 M51.9 M
Slightly volatile
Common Stock Total Equity9.9 K11.7 K13.1 K
Pretty Stable
Common Stock Shares Outstanding862 K1.1 M1.1 M
Slightly volatile
Short Term Investments29.7 M22.6 M37.8 M
Slightly volatile
Long Term Debt Total16.7 M30.1 M20.2 M
Slightly volatile
Liabilities And Stockholders Equity43.2 M35.1 M54.7 M
Slightly volatile
Capital Surpluse177.8 M333.7 M155.7 M
Slightly volatile
Other Current Assets831.3 K1.1 M1.1 M
Slightly volatile
Total Liabilities3.1 M3.3 M16.4 M
Slightly volatile
Total Current Assets41.8 M34.5 M53 M
Slightly volatile
Common Stock43.5 K41.4 K19.1 K
Slightly volatile
Property Plant Equipment82.9 K87.3 K582.1 K
Pretty Stable
Short Term Debt3.2 M4.3 M5.6 M
Slightly volatile
Capital Stock43.5 K41.4 K11.2 K
Slightly volatile
Net Working Capital38.9 M39.9 M19.1 M
Slightly volatile
Deferred Long Term Liabilities158 K95.4 K234.4 K
Slightly volatile

Forte Biosciences Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Interest Income1.3 M1.3 M724.3 K
Slightly volatile
Depreciation And Amortization7.7 K8.1 K168.1 K
Slightly volatile
Selling General Administrative7.6 M12.2 M6.3 M
Slightly volatile
Other Operating Expenses21.5 M29.2 M25.5 M
Very volatile
Research Development16.1 M19.7 M19.5 M
Pretty Stable
Total Operating Expenses21.5 M29.2 M25.5 M
Very volatile
Tax Provision855900956.1 K
Slightly volatile
Net Interest Income1.4 M1.3 M267.8 K
Slightly volatile
Cost Of Revenue7.7 K8.1 K14.6 K
Pretty Stable

Forte Biosciences Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
End Period Cash Flow33.3 M42.7 M23 M
Slightly volatile
Begin Period Cash Flow28 M47.3 M20.5 M
Slightly volatile
Stock Based Compensation2.7 MM3.8 M
Slightly volatile
Net Borrowings504.1 K567.1 K618.3 K
Slightly volatile
Change To Netincome4.7 M4.9 M3.5 M
Slightly volatile
Issuance Of Capital Stock23.4 M22.3 M14.7 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio9.9810.52.2 K
Slightly volatile
Average PayablesM947.1 K950.5 K
Slightly volatile
Stock Based Compensation To Revenue0.420.4454.4771
Slightly volatile
Capex To Depreciation9.248.85.3295
Slightly volatile
EV To Sales9.099.572.3 K
Slightly volatile
Payables Turnover0.00690.00730.0112
Pretty Stable
Sales General And Administrative To Revenue0.01610.016947.0035
Slightly volatile
Research And Ddevelopement To Revenue3.063.22222
Slightly volatile
Capex To Revenue0.120.133.4232
Slightly volatile
Cash Per Share32.1233.81787
Slightly volatile
Days Payables Outstanding54.6 K52 K47.5 K
Pretty Stable
Income Quality0.811.050.8168
Slightly volatile
Current Ratio9.049.4110.6783
Pretty Stable
Capex Per Share0.07610.08015.9009
Pretty Stable
Graham Net Net28.9530.47479
Slightly volatile
Revenue Per Share319303166
Slightly volatile
Interest Debt Per Share114120255
Slightly volatile
Debt To Assets1.081.030.6556
Slightly volatile
Days Of Payables Outstanding54.6 K52 K47.5 K
Pretty Stable
Total Debt To Capitalization2.071.971.1279
Slightly volatile
Quick Ratio9.049.4110.6783
Pretty Stable
Net Income Per E B T0.940.91.0531
Very volatile
Cash Ratio2.792.945.5403
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.820.90.997
Slightly volatile
Fixed Asset Turnover4.294.092.2753
Slightly volatile
Debt Ratio1.081.030.6556
Slightly volatile
Price Sales Ratio9.9810.52.2 K
Slightly volatile
Asset Turnover0.170.160.0867
Slightly volatile

Forte Biosciences Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap28.3 M29.8 M137.2 M
Slightly volatile
Enterprise Value15.3 M16.1 M132.8 M
Slightly volatile

Forte Fundamental Market Drivers

Cash And Short Term Investments37.1 M

Forte Upcoming Events

29th of March 2024
Upcoming Quarterly Report
View
20th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
29th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Forte Biosciences Financial Statements

Forte Biosciences investors use historical fundamental indicators, such as Forte Biosciences' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Forte Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue-4.3 M-4.1 M
Cost Of Revenue8.1 K7.7 K
Stock Based Compensation To Revenue 0.44  0.42 
Sales General And Administrative To Revenue 0.02  0.02 
Research And Ddevelopement To Revenue 3.22  3.06 
Capex To Revenue 0.13  0.12 
Revenue Per Share 303.45  318.63 
Ebit Per Revenue(2.29)(2.40)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Forte Stock Analysis

When running Forte Biosciences' price analysis, check to measure Forte Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Forte Biosciences is operating at the current time. Most of Forte Biosciences' value examination focuses on studying past and present price action to predict the probability of Forte Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Forte Biosciences' price. Additionally, you may evaluate how the addition of Forte Biosciences to your portfolios can decrease your overall portfolio volatility.